These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36054188)

  • 21. Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.
    Rahman T; Hamzan NS; Mokhsin A; Rahmat R; Ibrahim ZO; Razali R; Thevarajah M; Nawawi H
    Lipids Health Dis; 2017 Apr; 16(1):81. PubMed ID: 28438163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial hypercholesterolemia in Chinese patients with premature ST-segment-elevation myocardial infarction: Prevalence, lipid management and 1-year follow-up.
    Auckle R; Su B; Li H; Xu S; Xie M; Song Y; Abdul Quddus M; Xu Y; Liu B; Che W
    PLoS One; 2017; 12(10):e0186815. PubMed ID: 29088271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary risk factor profiles according to different age categories in premature coronary artery disease patients who have undergone percutaneous coronary intervention.
    Nazli SA; Rosman A; Mohd Kasim NA; Al-Khateeb A; Ul-Saufie AZ; Md Radzi AB; Ibrahim KS; Kasim SS; Nawawi H
    Sci Rep; 2024 Jul; 14(1):15326. PubMed ID: 38961082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of familial hypercholesterolemia in patients with myocardial infarction: A Chinese cohort study.
    Li S; Zhang Y; Zhu CG; Guo YL; Wu NQ; Gao Y; Qing P; Li XL; Sun J; Liu G; Dong Q; Xu RX; Cui CJ; Li JJ
    J Clin Lipidol; 2016; 10(6):1344-1352. PubMed ID: 27919351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial hypercholesterolemia among unselected contemporary patients presenting with first myocardial infarction: Prevalence, risk factor burden, and impact on age at presentation.
    Mortensen MB; Kulenovic I; Klausen IC; Falk E
    J Clin Lipidol; 2016; 10(5):1145-1152.e1. PubMed ID: 27678431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia.
    Tada H; Kawashiri MA; Nohara A; Inazu A; Mabuchi H; Yamagishi M
    Eur Heart J; 2017 May; 38(20):1573-1579. PubMed ID: 28159968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.
    Li S; Wu NQ; Zhu CG; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Sun J; Liu G; Dong Q; Li JJ
    Atherosclerosis; 2017 May; 260():67-74. PubMed ID: 28351002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Familial Hypercholesterolaemia in Acute Coronary Syndrome Patients in a Large Regional Coronary Care Unit.
    Samuel R; Birdsey G; Amerena J
    Heart Lung Circ; 2021 May; 30(5):730-733. PubMed ID: 33132051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study.
    Harada-Shiba M; Ako J; Arai H; Hirayama A; Murakami Y; Nohara A; Ozaki A; Uno K; Nakamura M
    Atherosclerosis; 2018 Oct; 277():362-368. PubMed ID: 30270072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).
    Descamps OS; Van Caenegem O; Hermans MP; Balligand JL; Beauloye C; Bondue A; Carlier S; Castermans E; Chenot F; Claeys M; De Block C; de Leener A; De Meester A; Demeure F; De Raedt H; Desmet W; Elegeert I; Guillaume M; Hoffer E; Kacenelenbogen R; Lancellotti P; Langlois M; Leone A; Mertens A; Paquot N; Vanakker O; Vanoverschelde JL; Verhaegen A; Vermeersch P; Wallemacq C; Rietzschel E;
    Atherosclerosis; 2018 Oct; 277():369-376. PubMed ID: 30270073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.
    Benn M; Watts GF; Tybjærg-Hansen A; Nordestgaard BG
    Eur Heart J; 2016 May; 37(17):1384-94. PubMed ID: 26908947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and management of familial hypercholesterolemia in patients with coronary artery disease: The heredity survey.
    Faggiano P; Pirillo A; Griffo R; Ambrosetti M; Pedretti R; Scorcu G; Werren M; Febo O; Malfatto G; Favretto G; Sarullo F; Antonini-Canterin F; Zobbi G; Temporelli P; Catapano AL;
    Int J Cardiol; 2018 Feb; 252():193-198. PubMed ID: 29249427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice.
    Pang J; David Marais A; Blom DJ; Brice BC; Silva PR; Jannes CE; Pereira AC; Hooper AJ; Ray KK; Santos RD; Watts GF
    Atherosclerosis; 2018 Oct; 277():470-476. PubMed ID: 30270087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals.
    Dyrbuś K; Gąsior M; Desperak P; Osadnik T; Nowak J; Banach M
    Atherosclerosis; 2019 Sep; 288():33-41. PubMed ID: 31319356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit.
    Pang J; Poulter EB; Bell DA; Bates TR; Jefferson VL; Hillis GS; Schultz CJ; Watts GF
    J Clin Lipidol; 2015; 9(5):703-8. PubMed ID: 26350818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What Causes Premature Coronary Artery Disease?
    Le A; Peng H; Golinsky D; Di Scipio M; Lali R; Paré G
    Curr Atheroscler Rep; 2024 Jun; 26(6):189-203. PubMed ID: 38573470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevalence and clinical features of familial hypercholesterolemia in Chinese patients with myocardial infarction].
    Sun D; Li S; Zhu CG; Guo YL; Wu NQ; Gao Y; Qing P; Zhang Y; Liu G; Dong Q; Li JJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):109-113. PubMed ID: 29495233
    [No Abstract]   [Full Text] [Related]  

  • 39. Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease.
    Yudi M; Omera L; McCubbery N; Dick S; Jayasinghe R; Hamilton-Craig I
    Singapore Med J; 2012 Mar; 53(3):174-8. PubMed ID: 22434290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of peripheral vascular disease in familial hypercholesterolaemia.
    Kroon AA; Ajubi N; van Asten WN; Stalenhoef AF
    J Intern Med; 1995 Nov; 238(5):451-9. PubMed ID: 7595185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.